𝔖 Bobbio Scriptorium
✦   LIBER   ✦

47. A randomized trial of concurrent tamoxifen (TAM) and cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM and delayed CEF after 6 months of endocrine therapy in metastatic breast cancer

✍ Scribed by P. Pfeiffer; C. Rose; B. Ejlertsen; M. Andersson; D. Pedersen; H.T. Mouridsen


Book ID
113404555
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
146 KB
Volume
4
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.